Transcatheter aortic valve implantation in low ejection fraction/low transvalvular gradient patients: the rule of 40

Federico Conrotto1, Fabrizio D'Ascenzo, Pieter Stella

  • 1aDivision of Cardiology, Città Della Salute e della Scienza Hospital, Turin, Italy bDepartment of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands cDivision of Cardiology, Istituto Clinico Humanitas dDepartment of Cardiology, Clinical Institute S. Ambrogio, Milan eDepartment of Cardiac, Thoracic and Vascular Sciences, Division of Cardiology, University of Padova, Padova fDivision of Cardiology, Policlinico Sant'Orsola-Malpighi, Bologna gDivision of Cardiac Surgery, Città Della Salute e della Scienza Hospital, University of Turin, Turin, Italy.

Insights

Patients undergoing transcatheter aortic valve implantation (TAVI) with both low left ventricular ejection fraction (LVEF) and low mean transaortic gradient (MTG) face higher mortality. Having at least one normal parameter predicts a good prognosis after TAVI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Predictors of outcomes after transcatheter aortic valve implantation (TAVI) are established, yet the roles of left ventricular ejection fraction (LVEF) and mean transaortic gradient (MTG) remain debated.
  • This multicenter study investigates the prognostic significance of reduced LVEF and MTG in TAVI patients.

Purpose of the Study:

  • To clarify the prognostic value of low LVEF and low MTG following TAVI.
  • To identify patient subgroups at higher risk of mortality post-TAVI.

Main Methods:

  • A cohort of 764 patients undergoing TAVI for severe symptomatic aortic valve stenosis between 2007 and 2012 was analyzed.
  • Patients were stratified into four groups based on LVEF (≤40% vs. >40%) and MTG (<40 mmHg vs. ≥40 mmHg).

Main Results:

  • Two-year mortality was significantly higher in patients with both low LVEF and low MTG (51.3%) compared to other groups (22.4%-25.5%).
  • Multivariate analysis identified the combination of low LVEF and low MTG as the strongest predictor of mid-term mortality (HR 2.4; P=0.001).

Conclusions:

  • A normal LVEF or MTG (above 40) predicts a favorable mid-term prognosis after TAVI.
  • Patients with concurrent left ventricular dysfunction and a low mean aortic pressure gradient exhibit a high risk of all-cause mortality post-TAVI.
Abstract